Our basic and clinical research translates into advances for the care of our patients as well as individuals suffering with skin diseases around the world. We are one of the top thirty-five National Institutes of Health-funded dermatology departments in the country, and continue to be a site of choice for national clinical research trials.
In our basic science laboratories, Diane Thiboutot, M.D., explores the mechanisms that promote and cause acne - opening opportunities for the discovery of new and safer drugs to treat this disease. Our other basic scientists, Drs., Robertson and Glick investigate melanoma and skin cancer. Our clinical research group tests new pharmaceuticals and devices in the treatment of psoriasis, skin cancers, eczema, skin infections, and other skin diseases.
In addition, the Penn State Skin Disease Program is a multi-disciplinary approach to investigate the biology and treatment of cutaneous disorders.